Lv52
1408 积分 2021-08-24 加入
Molecular mechanism of IgE-mediated FcεRI activation
5天前
已完结
Interleukin-33 in health and disease
21天前
已完结
The superiority of MabSelect VL, Cytiva's second-generation Protein L resin, over three other affinity resins in purifying a VHH-containing trispecific antibody
26天前
已完结
Dual-epitope targeting of TSLP to simultaneously block TSLPR and IL-7Rα with a Biparatopic nanobody
1个月前
已完结
The complex patent situation regarding antibody Fc engineering
2个月前
已完结
Anti‐BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc‐dependent and Fc‐independent mechanisms
2个月前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
2个月前
已完结
Dual agonism and selective T-cell depletion activity of a PD-1-directed antibody for treating autoimmune diseases
3个月前
已完结
Signalling through C-type lectin receptors: shaping immune responses
3个月前
已完结
OP0221 LBL-047, A NOVEL AFUCOSYLATED ANTI-BDCA2/TACI FUSION PROTEIN WITH YTE MUTATION, INHIBITS THE FUNCTIONS OF BOTH pDCs AND B CELLS
3个月前
已完结
皖公网安备34019202002308
